Nobuhisa Hagiwara

Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)

Hiroshi Kasanuki, Nobuhisa Hagiwara, S Hosoda et al. · European Heart Journal · 2009 · 110 citations · Full text

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry

Tsuyoshi Shiga, Nobuhisa Hagiwara, Hiroshi Ogawa et al. · Heart · 2008 · 110 citations

An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents β-aminopropionitrile monofumarate-induced aortic dissection in rats

Hirotaka Nagashima, Kento Uto, Yasunari Sakomura et al. · Journal of Vascular Surgery · 2002 · 53 citations · Full text

Molecular Pharmacology, Hypertension, Cardiovascular Disease +10

Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015)　― Digest Version ―

Kazutaka Aonuma, Tsuyoshi Shiga, Hirotsugu Atarashi et al. · Circulation Journal · 2017 · 46 citations · Full text

Improved Culture-Based Isolation of Differentiating Endothelial Progenitor Cells from Mouse Bone Marrow Mononuclear Cells

Haruki Sekiguchi, Masaaki Ii, Kentaro Jujo et al. · PLoS ONE · 2011 · 35 citations · Full text

Regenerative Medicine, Epc-rich Population, Culture-based Isolation +14